211
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of Inflammatory Markers in the Diagnosis of Metabolic Syndrome in Hemodialysis Patients: A Multicenter Observational Study

, , , , , , & ORCID Icon show all
Pages 1995-2002 | Published online: 04 Jul 2022

References

  • Vogt BP, Ponce D, Caramori JC. Anthropometric indicators predict metabolic syndrome diagnosis in maintenance hemodialysis patients. Nutr Clin Pract. 2016;31(3):368–374. doi:10.1177/0884533615601849
  • Tsangalis G, Papaconstantinou S, Kosmadakis G, Valis D, Zerefos N. Prevalence of the metabolic syndrome in hemodialysis. Int J Artif Organs. 2007;30(2):118–123. doi:10.1177/039139880703000206
  • Duong TV, Wong TC, Chen HH, et al. Inadequate dietary energy intake associates with higher prevalence of metabolic syndrome in different groups of hemodialysis patients: a clinical observational study in multiple dialysis centers. BMC Nephrol. 2018;19(1):236. doi:10.1186/s12882-018-1041-z
  • Sanguankeo A, Upala S. Metabolic syndrome increases mortality risk in dialysis patients: a systematic review and meta-analysis. Int J Endocrinol Metab. 2018;16(2):e61201. doi:10.5812/ijem.61201
  • Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28–iii34. doi:10.1093/ndt/gfy174
  • Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016;167(1):257–280. doi:10.1016/j.trsl.2015.06.017
  • Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009;20(3):182–189. doi:10.1097/MOL.0b013e32832ac03e
  • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–843. doi:10.1056/NEJM200003233421202
  • Saisho Y, Hirose H, Roberts R, Abe T, Kawabe H, Itoh H. C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the Japanese general population: a longitudinal cohort study. PLoS One. 2013;8(9):e73430. doi:10.1371/journal.pone.0073430
  • Nowak KL, Chonchol M. Does inflammation affect outcomes in dialysis patients? Semin Dial. 2018;31(4):388–397. doi:10.1111/sdi.12686
  • Shahrokh S, Heydarian P, Ahmadi F, Saddadi F, Razeghi E. Association of inflammatory biomarkers with metabolic syndrome in hemodialysis patients. Ren Fail. 2012;34(9):1109–1113. doi:10.3109/0886022X.2012.713280
  • Park JT, Chang TI, Kim DK, et al. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis. Metabolism. 2009;58(10):1379–1385. doi:10.1016/j.metabol.2009.05.002
  • Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. doi:10.1249/01.MSS.0000078924.61453.FB
  • Jagadeswaran D, Indhumathi E, Hemamalini AJ, Sivakumar V, Soundararajan P, Jayakumar M. Inflammation and nutritional status assessment by malnutrition inflammation score and its outcome in pre-dialysis chronic kidney disease patients. Clin Nutr. 2019;38(1):341–347. doi:10.1016/j.clnu.2018.01.001
  • Rattanasompattikul M, Feroze U, Molnar MZ, et al. Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients. Int Urol Nephrol. 2012;44(6):1813–1823. doi:10.1007/s11255-011-0085-9
  • Song P, Zhang Y, Wang Y, et al. Clinical relevance of different handgrip strength indexes and metabolic syndrome in Chinese community-dwelling elderly individuals. Arch Gerontol Geriatr. 2020;87:104010. doi:10.1016/j.archger.2020.104010
  • Han P, Yu H, Ma Y, et al. The increased risk of sarcopenia in patients with cardiovascular risk factors in Suburb-Dwelling older Chinese using the AWGS definition. Sci Rep. 2017;7(1):9592. doi:10.1038/s41598-017-08488-8
  • Ma Y, Fu L, Jia L, et al. Muscle strength rather than muscle mass is associated with osteoporosis in older Chinese adults. J Formos Med Assoc. 2018;117(2):101–108. doi:10.1016/j.jfma.2017.03.004
  • Yao Z, Gu Y, Zhang Q, et al. Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. Eur J Nutr. 2019;58(2):819–830. doi:10.1007/s00394-018-1713-2
  • Gu Y, Li X, Zhang Q, et al. Grip strength and depressive symptoms in a large-scale adult population: the TCLSIH cohort study. J Affect Disord. 2021;279:222–228. doi:10.1016/j.jad.2020.08.023
  • Zhou C, Zhan L, Yuan J, Tong X, Peng Y, Zha Y. Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients. Eat Weight Disord. 2020;25(3):727–734. doi:10.1007/s40519-019-00678-9
  • Young DO, Lund RJ, Haynatzki G, Dunlay RW. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int. 2007;11(1):86–95. doi:10.1111/j.1542-4758.2007.00158.x
  • den Engelsen C, Koekkoek PS, Gorter KJ, van den Donk M, Salome PL, Rutten GE. High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis. Cardiovasc Diabetol. 2012;11:25. doi:10.1186/1475-2840-11-25
  • Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern Med. 2007;46(13):945–951. doi:10.2169/internalmedicine.46.0092
  • Zawada AM, Carrero JJ, Wolf M, et al. Serum uric acid and mortality risk among hemodialysis patients. Kidney Int Rep. 2020;5(8):1196–1206. doi:10.1016/j.ekir.2020.05.021
  • Pugliese NR, Mengozzi A, Virdis A, et al. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk. Clin Res Cardiol. 2021;110(7):1073–1082. doi:10.1007/s00392-021-01815-0
  • Antlanger M, Aschauer S, Kopecky C, et al. Heart failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis. Kidney Blood Press Res. 2017;42(1):165–176. doi:10.1159/000473868
  • Pugliese NR, Mazzola M, Madonna R, et al. Exercise-induced pulmonary hypertension in HFpEF and HFrEF: different pathophysiologic mechanism behind similar functional impairment. Vascul Pharmacol. 2022;144:106978. doi:10.1016/j.vph.2022.106978
  • Grad E, Golomb M, Mor-Yosef I, et al. Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. Am J Physiol Heart Circ Physiol. 2007;293(1):H489–95. doi:10.1152/ajpheart.01418.2006
  • Teoh H, Quan A, Lovren F, et al. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis. 2008;201(2):318–325. doi:10.1016/j.atherosclerosis.2008.02.034
  • Rodriguez CJ, Miyake Y, Grahame-Clarke C, et al. Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol. 2005;96(9):1273–1277. doi:10.1016/j.amjcard.2005.06.070
  • Keaney JF, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23(3):434–439. doi:10.1161/01.ATV.0000058402.34138.11
  • Devaraj S, Dasu MR, Singh U, Rao LV, Jialal I. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis. 2009;203(1):67–74. doi:10.1016/j.atherosclerosis.2008.05.060
  • Yang XJ, Tian S, Ma QH, Sun HP, Xu Y, Pan CW. Leukocyte-related parameters in older adults with metabolic syndrome. Endocrine. 2020;68(2):312–319. doi:10.1007/s12020-020-02243-2
  • Oda E, Kawai R. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med. 2010;49(2):117–124. doi:10.2169/internalmedicine.49.2670